Overview

Immunoprecipitation Market Introduction

Global Immunoprecipitation Market to value over USD 720 Million and register a CAGR of over 4% during the forecast period 2020 to 2027.

The immunoprecipitation market is witnessing significant growth due to a rise in research activities undertaken in the medical and life sciences industry. The research is usually sponsored and receives federal support which is also regarded as a substantial factor adding to the market’s growth during the forecast period. In order to identify antigens associated with autoimmune diseases, the market plays a key role and thus is profoundly demanded. The factors for early diagnosis of antigens, accuracy and speed are driving market growth.

Based on type, the market is segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation and RNA immunoprecipitation. Individual immunoprecipitation is projected to be the fastest-growing sector during the forecasted time frame and register a healthy CAGR. The wide application spectrum offered by individual immunoprecipitation is a principal factor aiding its growth and highly precise diagnosis capability also aid in the expansion of the immunoprecipitation market size.

By product type, the market is segmented into kits, reagents and accessories. The kits segment is expected to grow at a healthy CAGR due to their employment in various processes. Heavy demand due to universal operability encourages the growth of this segment.

Based on the region, The Asia Pacific is predicted to grow at the highest CAGR during the forecast period. Federal support and increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period. North America is predicted to garner major market share due to the presence of global players and developed medical practices.

Prominent players are Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, GenScript., and BioLegend and Cell Signaling Technology.

Competitive Landscape 

●     Thermo Fisher Scientific opened its new bioprocess design centre in Shanghai to connect and collaborate with biologic developers to design optimal bioprocessing solutions

●     Abcam entered into an agreement with Roche, a leading biotech company, under which Abcam obtained the exclusive rights to the product portfolio of Spring, which consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products

Market Segmentation 

By Type

●      Individual Immunoprecipitation

●     Co-Immunoprecipitation

●     Chromatin Immunoprecipitation

●     RNA Immunoprecipitation    

By Product

●     Kits

●     Reagents

■              Antibodies

➢              By Type

○       Primary Antibodies

○       Secondary Antibodies

■                Beads

➢              By Type

○     Agarose Beads

○     Magnetic Beads

○      Buffers

●      Accessories

By End User

●     Academic & Research Institutes

●     Pharmaceutical & Biotechnology Companies

●     Contract Research Organizations

By Region

●     North America

●     Europe

●     Asia Pacific

●     Latin America

●     Middle East & Africa

Objectives of the Study:

●     To provide with an exhaustive analysis on the global immunoprecipitation market by type, by product, by end-user, and by region

●     To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

●      To evaluate and forecast micro-markets and the overall market

●      To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

●      To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

●      Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

    1.3 Market Scope 

           1.3.1 Markets Covered

           1.3.2 Years Considered for the Study

    1.4 Currency 

    1.5 Stakeholders 

    1.6 Limitations 

2 Research Methodology 

    2.1 Research Approach 

           2.1.1 Secondary Research

                    2.1.1.1 Key Data From Secondary Sources

           2.1.2 Primary Research

                    2.1.2.1 Key Data From Primary Sources

                    2.1.2.2 Break Down of Primaries

                    2.1.2.3 Key Industry Insights

    2.2 Market Size Estimation 

    2.3 Data Triangulation Approach 

    2.4 Assumptions for the Study 

3 Executive Summary 

4 Premium Insights 

    4.1 Immunoprecipitation: Market Overview 

    4.2 Immunoprecipitation Market, By Product (2020–2027) 

    4.3 North America: Immunoprecipitation Market, By Type (2020) 

5 Market Overview

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Market Drivers

                    5.2.1.1 Increasing Number of Life Sciences Research Activities

                    5.2.1.2 Growing Need to Identify Antigens That are Associated With Autoimmune Diseases

           5.2.2 Restraints

                    5.2.2.1 Presence of Alternative Technologies

           5.2.3 Opportunities

                    5.2.3.1 Increasing Focus on Biomarker Discovery

           5.2.4 Challenges

                    5.2.4.1 Quality Concerns Over Research Antibodies

6  By Type 

    6.1 Introduction 

    6.2 Individual Immunoprecipitation 

           6.2.1 Increasing Demand for Biologics is Driving the Growth of the Market

    6.3 Co-Immunoprecipitation 

           6.3.1 Increasing Use of Co-Ip to Study Protein Complexes Forms A Key Market Driver

    6.4 Chromatin Immunoprecipitation 

           6.4.1 Growing Adoption of High-Throughput Technologies Will Contribute to Adoption of Chip

    6.5 Rna Immunoprecipitation 

           6.5.1 Availability of Government Funding Will Drive the Adoption of Rip Kits

7 By Product 

    7.1 Introduction 

    7.2 Kits 

           7.2.1 Kits Segment to Account for the Largest Share of the Immunoprecipitation Market During the Forecast Period

    7.3 Reagents 

           7.3.1 Antibodies

                    7.3.1.1 Antibodies, By Type

                               7.3.1.1.1 Primary Antibodies

                                             7.3.1.1.1.1 Primary Antibodies to Account for the Largest Share of the Immunoprecipitation Antibodies Market During the Forecast Period

                               7.3.1.1.2 Secondary Antibodies

                                             7.3.1.1.2.1 Low Cost of Production - A Major Factor Driving the Growth of the Secondary Antibodies Market

           7.3.2 Beads

                    7.3.2.1 Beads, By Type

                    7.3.2.2 Agarose Beads

                               7.3.2.2.1 High Binding Capacity and Lower Cost – Factors Supporting the Wide Use of Agarose Beads in Research Laboratories

                    7.3.2.3 Magnetic Beads

                               7.3.2.3.1 Magnetic Bead-Based Separation Helps Increase Throughput and Reduces Hands-On Time

                    7.3.2.4 Buffers

                               7.3.2.4.1 Buffer Solutions Play an Important Role in Maintaining Ph Balance in Ip Assays

    7.4 Accessories 

8  By End User 

    8.1 Introduction 

    8.2 Academic & Research Institutes 

           8.2.1 Academic & Research Institutes are the Largest End Users of Immunoprecipitation

    8.3 Pharmaceutical & Biotechnology Companies 

           8.3.1 Increasing Demand for Protein-Based Drugs to Drive the Demand for Immunoprecipitation in This End-User Segment

    8.4 Contract Research Organizations 

           8.4.1 Growth in Outsourcing of Protein Purification Activities - A Major Factor Driving the Demand for Immunoprecipitation Technologies in Contract Research Organizations

9  By Region 

    9.1 Introduction 

    9.2 North America 

           9.2.1 Us

                    9.2.1.1 Growing Research Will Drive Market Growth

           9.2.2 Canada

                    9.2.2.1 Increasing Genomics and Proteomics Research to Drive the Adoption of Immunoprecipitation in the Coming Years

    9.3 Europe 

           9.3.1 Growth of the Life Sciences Sector Will Support the Demand for Immunoprecipitation

    9.4 Asia Pacific 

           9.4.1 Increasing Demand for Novel Antibody and Protein-Based Drugs Support Market Growth in the Asia Pacific

    9.5 Rest of the World 

10 Competitive Landscape 

     10.1 Overview 

     10.2 Vendor Benchmarking 

     10.3 Competitive Leadership Mapping 

             10.3.1 Visionary Leaders

             10.3.2 Innovators

             10.3.3 Dynamic Differentiators

             10.3.4 Emerging Companies

     10.4 Market Ranking Analysis, 2020

     10.5 Competitive Situation and Trends 

             10.5.1 Expansions

             10.5.2 Collaborations, Partnerships, and Agreements

             10.5.3 Product Launches

             10.5.4 Acquisitions

11 Company Profiles 

(Business Overview, Products Offered, Recent Developments, FutureWise Perspective)*

     11.1 Thermo Fisher Scientific 

     11.2 Abcam 

     11.3 Genscript 

     11.4 Merck KGaA 

     11.5 Bio-Rad Laboratories 

     11.6 Biolegend 

     11.7 Takara Bio 

     11.8 Rockland Immunochemicals 

     11.9 Cell Signaling Technology 

     11.10 Geno Technology

12. Assumptions and Acronyms 

13. Research Methodology 

14. List of Sources of Information (Primary and Secondary) 

Tables

Figures